---
title: "Thermo Fisher surges 10% on raised FY2026 guidance and dividend"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293628243.md"
description: "Thermo Fisher (TMO.US) jumped 10% during regular trading after raising FY2026 EPS and revenue guidance above estimates."
datetime: "2026-07-23T13:41:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293628243.md)
  - [en](https://longbridge.com/en/news/293628243.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293628243.md)
generator: "portal-rs"
---

# Thermo Fisher surges 10% on raised FY2026 guidance and dividend

赛默飞世尔 (TMO.US) 盘中涨超**10%**，现报**579.8 美元**。此次异动为近一年最大盘中涨幅。

消息面上，公司当日更新了 2026 财年业绩指引，预计每股收益**24.93-25.33 美元**，营收**474-481 亿美元**，均略高于市场预期。公司同时宣布每股派发季度股息**0.47 美元**。

### Related Stocks

- [TMO.US](https://longbridge.com/en/quote/TMO.US.md)

## Related News & Research

- [Nykredit A S Purchases Shares of 115,085 Thermo Fisher Scientific Inc. $TMO](https://longbridge.com/en/news/297893974.md)
- [Thermo Fisher President, COO Gianluca Pettiti reports Thermo Fisher share disposal worth $3.24 million](https://longbridge.com/en/news/297692718.md)
- [Thermo Fisher Scientific (TMO) Launches New Research Tools As Fair Value Debate Tightens](https://longbridge.com/en/news/297419322.md)
- [48,493 Shares in Thermo Fisher Scientific Inc. $TMO Purchased by United Capital Financial Advisors LLC](https://longbridge.com/en/news/297307715.md)
- [10:30 ETClinical Trials Services Market worth $97.41 billion by 2031 - Exclusive Report by MarketsandMarkets™](https://longbridge.com/en/news/298051641.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**